Arş. Gör. MUSTAFA EMRE DUYGULU | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

Beypinar I., Demir H., YASLIKAYA Ş., Koeseci T., Demir B., Colak G., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.208, sa.3, ss.597-604, 2024 (SCI-Expanded)

CDK4/6 Inhibitor-Associated Mean Corpuscular Volume Change: A Potential Parameter for Predicting Survival in Metastatic Breast Cancer?

Yildirim A., DUYGULU M. E., FİDAN E.

Journal of the College of Physicians and Surgeons Pakistan , cilt.34, sa.7, ss.785-789, 2024 (SCI-Expanded)

Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung

DUYGULU M. E., AŞIK E., TÜKENMEZ M. A., TEOMAN G., Yildirim A., FİDAN E.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.70, sa.9, 2024 (SCI-Expanded)

Relationship between Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and Thrombosis in Patients with Portal Vein Thrombosis (PVT) without Acquired Risk Factor for Thrombosis

DUYGULU M. E., Ayyıldız T., Yildirim B., Zorlu B. Ş., Gören İ., Bektaş A.

Nigerian journal of clinical practice , cilt.27, sa.1, ss.89-94, 2024 (SCI-Expanded)

Prognostic Factors Associated with Resected Osteosarcoma: Efficacy of Adjuvant Setting, Real-World Experience

Majidova N., Simsek F., Biter S., YASLIKAYA Ş., Seyyar M., DUYGULU M. E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.34, sa.1, ss.20-27, 2024 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation

DUYGULU M. E., YILDIRIM A., AYAS E., ALYILDIZ N., Mungan S. A., FİDAN E.

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY , cilt.45, sa.2, ss.127-133, 2024 (ESCI)

Creative Commons License

Metrikler

Yayın

6

Açık Erişim

1